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Abstract
Background: Genomic imprinting evolved in a common ancestor to marsupials and eutherian mammals and
ensured the transcription of developmentally important genes from defined parental alleles. The regulation of
imprinted genes is often mediated by differentially methylated imprinting control regions (ICRs) that are
bound by different proteins in an allele-specific manner, thus forming unique chromatin loops regulating
enhancer-promoter interactions. Factors that maintain the allele-specific methylation therefore are essential for
the proper transcriptional regulation of imprinted genes. Binding of CCCTC-binding factor (CTCF) to the IGF2/
H19-ICR1 is thought to be the key regulator of maternal ICR1 function. Disturbances of the allele-specific
CTCF binding are causative for imprinting disorders like the Silver-Russell syndrome (SRS) or the Beckwith-
Wiedemann syndrome (BWS), the latter one being associated with a dramatically increased risk to develop
nephroblastomas.
Methods: Kaiso binding to the human ICR1 was detected and analyzed by chromatin immunoprecipitation (ChIP)
and electrophoretic mobility shift assays (EMSA). The role of Kaiso-ICR1 binding on DNA methylation was tested by
lentiviral Kaiso knockdown and CRISPR/Cas9 mediated editing of a Kaiso binding site.
Results: We find that another protein, Kaiso (ZBTB33), characterized as binding to methylated CpG repeats as well as
to unmethylated consensus sequences, specifically binds to the human ICR1 and its unmethylated Kaiso
binding site (KBS) within the ICR1. Depletion of Kaiso transcription as well as deletion of the ICR1-KBS by
CRISPR/Cas9 genome editing results in reduced methylation of the paternal ICR1. Additionally, Kaiso affects
transcription of the lncRNA H19 and specifies a role for ICR1 in the transcriptional regulation of this
imprinted gene.
Conclusions: Kaiso binding to unmethylated KBS in the human ICR1 is necessary for ICR1 methylation
maintenance and affects transcription rates of the lncRNA H19.
Background
Imprinting disorders (IDs) are rare congenital diseases
and arise from the dysregulation or mutation of imprinted
genes. Causative imprinted genes are clustered in groups
and regulated by the so-called imprinting control regions
(ICRs) that are differentially methylated (reviewed in [1]).
The human imprinting control region 1 (ICR1) located on
chromosome 11p15.5 regulates the allele-specific expres-
sion of the IGF2 and H19 genes. It contains two different
types of repetitive sequences (2 A- and 7-B-repeats) with
seven CTCF binding sites, six of which are located in B1,
B2, B3, B5, B6 and B7. The seventh CTCF binding site is
located downstream from A1. As well, in ICR1, A1 and
A2 are two OCT4 and two SOX2 binding sites [2].
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Differential parental methylation has been proposed
for all B-repeats harbouring CTCF target sites (CTS)
in most normal tissues [3–6] (see Fig. 1). The growth
disorders Beckwith-Wiedemann syndrome and Silver-
Russell syndrome are linked to opposite DNA methy-
lation defects involving the ICR1. OCT4 and SOX2
bind their target sites on the unmethylated maternal allele
and prevent a gain of methylation on this allele. Conse-
quently, CTCF binds to the CTS on the unmethylated ma-
ternal ICR1 and creates a functional chromatin boundary
thus blocking the interaction between shared enhancer el-
ements with the IGF2 promoters [7]. Studies in murine
models [8–11] as well as in human cells [12] have shown
that the higher-order chromatin structure of the maternal
and paternal Igf2/H19 domains differ and form character-
istic loops that confer the described effects and indicate
CTCF to be the master regulator of ICR1 function. On
the methylated paternal allele, CTCF binding is prevented
due to the methylation of the recognition site, triggering
IGF2 expression from the paternal allele by permitting the
promoter enhancer interactions [13–15]. This methylation
of the CTS in the ICR1 is established during late paternal
gametogenesis and maintained after fertilization of the
oocyte and in the somatic cells. Methylation of ICR1
generates binding sites for the zinc finger protein ZFP57
in all B-repeats. In other differentially methylated regions
(DMR), like KvDMR1/ICR2 in 11p15.5 or SNRPN in
15q11.2, binding of ZFP57/KAP1 to the methylated target
site leads to a ZFP57-dependent methylation maintenance
in ES cells [16]. However, methylation maintenance in the
ICR1 (and Igf2r-DMR) has been described to be independ-
ent of ZFP57 binding [17]. Another protein that may con-
tribute to the methylated ICR1-mediated effects is
ZBTB33 (Kaiso), a member of the pox virus and zinc fin-
ger (POZ) family of zinc finger (ZF) transcription factors
that can bind methylated CmGCmG motifs via its three
Krüppel-like C2H2 ZFs. In the presence of an appropriate
consensus sequence around a single CG dinucleotide, it
also recognizes the CmG motif [18]. Kaiso is known to as-
sociate with p120 catenin and is a constituent of one of
two methyl-CpG binding complexes originally designated
as MeCP1 [19]. It behaves as a methylation-dependent
transcriptional repressor. Filion and coworkers performed
chromatin immunoprecipitation (ChIP) with antibodies
Fig. 1 Human ICR1 is bound by Kaiso. a Schematic overview of the maternal human ICR1 consisting of two clusters each containing one 450-bp
(A-) repeat with OCT4/SOX2 binding sites, followed by three to four 400-bp (B-) repeats. Each B-repeat, with the exception of the shortened B4-repeat,
contains a CTS (black ovals) and a ZFP57 binding site. An optimal KBS (5′TNGCAGGA3′) resides in B4 (white oval). KBS-similar motifs (5′TNGCAGGC3′)
can be detected in repeats B1, B2, B3, B5 and B6. White lollipops indicate CGCG motives as putative binding sites for Kaiso when methylated.
b Chromatin immunoprecipitation (ChIP) with a specific anti-Kaiso antibody from primary fibroblast cell culture extracts indicates precipitation
of the B-repeat DNA (CTS containing repeats B1, B2, B3, B5 and B6) as well as ICR1-B4-DNA (B4-KBS). Binding of Kaiso to the known functional
KBS in the MMP7 promoter was used as a positive control for the ChIP. Data are represented as mean ± SEM from four independent ChIP
assays, and enrichment was normalized against the input. Relative DNA concentrations were analysed by qPCR indicating significant pulldowns for
MMP7, CTS and B4-KBS. P values for the individual pulldowns are indicated
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directed to Kaiso on murine brain extracts and showed
binding of Kaiso mostly, but not exclusively to the pater-
nal (methylated) ICR1 [20]. Kaiso is the only POZ-ZF pro-
tein known to be able to bind methylated CG motifs
[18, 19], as well as the specific DNA sequence 5′
TNGCAGGA3′ (Kaiso binding site (KBS)) with even
higher affinity [21]. It is unclear whether binding of Kaiso
to the KBS or methylated targets represent separate activ-
ities of Kaiso. Binding of Kaiso to the KBS seems to be
evolutionarily linked to the appearance of genomic im-
printing since only the methyl-CpG binding function of
Kaiso is evolutionarily conserved in frog, fish and chicken
[22], suggesting a distinct role for KBS in mammalian or-
ganisms. Therefore, we examined the human ICR1 for the
presence of consensus unmethylated Kaiso binding sites
[21] and uncovered a unique KBS (5′TGGCAGGA3′)
in the B4-repeat, which most interestingly has no CTS
(see Fig. 1a). Additionally, KBS cognate motifs (5′
TNGCAGGC3′) exist in B1, B2, B3, B5 and B6. The par-
tially binding of Kaiso to the unmethylated allele [20] and
the presence of a KBS, which can potentially be recog-
nized bound by Kaiso on both alleles, led us to investigate
whether Kaiso plays a role in the maintenance of human
genomic imprinting via binding at the ICR1.
Results
Kaiso binds the ICR1 in primary human fibroblasts
To determine whether Kaiso binds the ICR1 in primary
cells, we performed ChIP experiments with primary
human fibroblast cells that have a paternally methylated
and a maternally unmethylated ICR1 sequence. Full-
length ICR1-B fragments (B1, B2, B3, B5 and B6) as well
as the B4-repeat were detected in pulldowns from the
anti-Kaiso antibody (Fig. 1b). Based on the presence of
the CGCG motif, but not the CG motif in the optimal
sequence context [18] in every single B-repeat including
the B4-repeat, it is difficult to distinguish whether the
unmethylated KBS in B4 is directly occupied in vivo or if
the pulldown is occurring due to interactions with a
neighbouring CmGCmG site (see Fig. 1a). Precipitation
of the full-length B-repeats is 1.5-fold higher than the
precipitation of the B4-KBS-DNA, probably reflecting
the abundance of Kaiso binding within the methylated
B-repeats, compared to the single B4-KBS. Binding of
Kaiso to the known functional KBS in the MMP7
promoter [22] was used as a positive control for ChIP
and suggests binding of Kaiso to the ICR1 comparable
to the MMP7-promoter. These results indicate that
Kaiso binds the human ICR1 including its KBS in the
B4-repeat. While the full-length B-repeat binding is
observed on the methylated paternal allele, binding of
the B4-KBS can occur on both alleles, since the KBS
cannot be methylated.
Kaiso binds to unmethylated consensus sequence in the
human ICR1-B4-repeat
In vitro binding of Kaiso to fragments of the unmethylated
ICR1 was tested by EMSA using fluorescence double-
stranded oligonucleotide sequences harbouring the deter-
mined putative KBS sequences. The putative KBS located
in B4 [21] showed a mobility shift in the presence of Kaiso
in contrast to the cognate KBS of the B1-, B2-, B3-, B5-
Fig. 2 Kaiso binds the ICR1-B4-KBS in vitro. EMSA was carried out
with fluorescence-labelled oligonucleotide probes for the ICR1-B4-KBS
(lanes 1–8). N-terminal Flag-tagged Kaiso protein (in vitro FLAG-Kaiso)
was produced by in vitro translation, using modified HeLa cell extracts
(Pierce). The ds-oligo for the ICR1-B4-KBS (lane 1) is shifted by in
vitro FLAG-Kaiso—Kaiso (lanes 3 and 5), but not by the cell
extract containing the expression vector alone (neg. control, lane 2).
Complexes were competed by an excess of unlabelled ICR1-B4-KBS
ds-oligo (lane 4) but not with a non-specific control oligo (lane 5). In
supershift reactions, Flag-tagged Kaiso was incubated with anti-Kaiso
(lane 6), anti-WT1 (lane 7) or anti-Flag (lane 8) antibodies, the anti-WT1
representing a non-specific control
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and B6-repeats. The shift can be competed by an excess of
unlabelled KBS double-stranded oligonucleotide sequences
which abrogate Kaiso binding to ICR1-B4-KBS (Fig. 2).
Kaiso binding specificity to the ICR1-B4-KBS was further
confirmed using an anti-Kaiso antibody in a supershift
assay. Control reactions with unspecific WT1—instead of
Kaiso—antibody assure specificity of the supershift reac-
tions. These results demonstrate that Kaiso binds the KBS
in the B4-repeat of human ICR1 in vitro (Fig. 2).
Kaiso binding to the human ICR1 affects ICR1 methylation
and transcriptional activity of H19 and IGF2
To determine whether Kaiso binding to the ICR1 is
mediating the regulatory effects of the ICR1, we exam-
ined the effect of RNAi-mediated Kaiso knockdown. We
sought to chronically deplete Kaiso in primary human
fibroblast cells using a lentivirus expressing a shRNA-
targeting Kaiso. Following selection for stable integrants,
Kaiso-shRNA-expressing fibroblast cells had only ~32 %
of endogenous Kaiso mRNA (Fig. 3a) associated with a
reduction of endogenous ICR1 methylation to 23 %
compared to 46 % average methylation of the controls
(Fig. 3b). The Kaiso knockdown did not significantly
alter the differential methylation at the KvDMR1 of ~50 %
(Additional file 1: Figure S1A). The reduction in ICR1
methylation in the primary fibroblasts, correlated with a
significant transcriptional downregulation of IGF2 (15 %
of control) and of H19 transcripts (8 % of control) (Fig. 3a).
These data suggest a role for Kaiso in the methylation
maintenance of the paternal ICR1.
Kaiso binding to unmethylated KBS in human ICR1-B4 is
necessary for ICR1 methylation maintenance
As the observed effects of Kaiso binding on the methyla-
tion of the ICR1 could be due to binding to CmGCmG
sites as well as the unmethylated KBS in the B4-repeat
Fig. 3 Lentiviral-mediated Kaiso knockdown (Kaiso KD) is associated with a reduction of ICR1 methylation and decreased endogenous IGF2
and H19 transcription in human primary. As controls, transfections with shRNA against a scrambled locus (S.L.) were performed. a
Knockdown efficiency was quantitated by RT-qPCR. The expression values are normalized to PDH and B2M transcripts and are represented as
mean ± SEM from two independent experiments each. p values for the transcriptional comparisons are indicated. b ICR1 methylation was determined
by pyrosequencing of the three established differentially methylated ICR1 CpGs in bisulfite-treated DNA. The location of the analysed
CpGs is schematically depicted on top. Mean methylation values of three replicates are presented ± SEM for each CG position. The knockdown of Kaiso
is associated with reduced methylation of endogenous ICR1
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or even to genome-wide Kaiso depletion, we aimed to
directly perturb the Kaiso binding site. Since our data
suggested that a single unmethylated KBS exists in the
ICR1-B4-repeat, we edited this binding site in primary
fibroblasts using clustered regularly interspaced short
palindromic repeats (CRISPR)/CRISPR associated 9
(Cas9) genome editing [23]. Two synthetic guide RNAs
(sgRNA) targeting ICR1-B4-KBS were designed for dis-
ruption of ICR1-B4-KBS by non-homologous end join-
ing (NHEJ) (Fig. 4a). A sgRNA targeting the murine
Fig. 4 Genomic CRISPR/Cas9 deletion of the ICR1-B4-KBS leads to the loss of ICR1 methylation and transcriptional deregulation of H19 and IGF2.
a Sense and antisense sgRNAs (sg-ICR-s, sg-ICR-as) were designed to target the KBS site. Adjacent to both sgRNAs is the presence of a PAM
(5′NGG3′). After lentiviral transduction in primary fibroblasts with a differentially methylated ICR1 (50 % methylation), GFP+ cells were sorted by
FACS. The target sequence was amplified by PCR and subcloned, and a random selection of 20 clonal integrates was sequenced. Seven out of
these 20 clones showed a deletion of the target site. The smallest and largest of the detected Cas9-mediated deletions (ranging from 3 to 29 bp)
are depicted here to illustrate the deletion range. All detected deletions were found to disrupt the KBS motif. b Cas9-modified fibroblasts are
impaired for ICR1 methylation. For the following analyses, GFP+ cells were sorted by FACS and analysed as pooled cells. Displayed histogram
values are represented as mean ± SEM from four replicate analyses for each CG position. c Expression of H19 and IGF2 is altered upon KBS editing.
Expression values obtained by qRT-PCR from RNA of pooled FACS-sorted GFP+ cells were normalized against PDH and B2M transcripts and are
shown in mean ± SEM from 2 to 3 replicate analyses each
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Rosa26 locus was used as a neutral control [23]. Lenti-
viral transduction of fibroblasts was used to introduce
Cas9, each sgRNA and a GFP reporter. GFP+ cells were
sorted by flow cytometry and the B4-repeat was ampli-
fied by PCR and subcloned in pCDNA3. Sequencing
analyses detected deletions in 7 out of 20 clones ana-
lysed (Fig. 4a). The GFP+ sorted cells infected with the
B4-KBS targeting guide RNAs showed ~50 % reduction
of ICR1 methylation compared to the ICR1 methylation
observed in Rosa26-targeted fibroblasts (Fig. 4b). Like in
the Kaiso knockdown approaches, the ~50 % methyla-
tion of the KvDMR1 was not significantly altered in the
edited fibroblasts (Additional file 1: Figure 1B). This is
consistent with the notion that binding of Kaiso to its
unmethylated KBS in the B4-repeat of the ICR1 is neces-
sary to maintain methylation on the paternal ICR1 allele.
IGF2 and H19 transcription was significantly downregu-
lated after the disruption of the ICR1-B4-KBS (Fig. 4c).
It is also noteworthy to mention that the CRISPR/
Cas-edited fibroblasts had a reduced methylation of
the analysed ICR1 CpGs in both the Rosa26 controls
and in the two KBS-sgRNA approaches. This might
reflect a side effect of the editing machinery, although
it remains unclear why it affects only the ICR1.
Discussion
The presented results indicate that Kaiso binds to the
human ICR1 and to the KBS in the ICR1-B4-repeat.
Permanent downregulation of Kaiso results in a de-
creased methylation maintenance and a downregulation
of IGF2 and H19 transcription. In this setting, it remains
unclear if the observed effects are due to the general
downregulation of Kaiso, which alters the transcription
of a transfactor or reflects local effects of Kaiso binding
to the methylated CGCG sequences on the paternal
ICR1 and/or to the B4-KBS on both alleles. The CRISPR/
Cas9 approach suggests that the methylation maintenance
and the transcriptional effects are causally connected with
the binding of Kaiso to the B4-KBS. Our data does not
allow a determination as to whether Kaiso binds the latter
on both alleles, but the observed methylation effects of
Kaiso reduction and binding depletion suggest that KBS
binding on the methylated paternal allele is crucial.
How can Kaiso binding mediate the methylation main-
taining effects? We do not observe a complete demethyl-
ation after editing of ICR1-B4 KBS locus, which could
be ascribed to incomplete editing in the pooled cells.
Indeed, upon analysis of the GFP+ sorted primary fibro-
blasts, only approximately one third of the randomly
analysed target sequences showed editing at the target
site. In addition, since both parental ICR1 alleles can be
edited and the maternal allele is unmethylated, editing at
this locus will always provide a relative readout. Hence,
the observed demethylation strongly suggests that Kaiso
binding to the ICR1-B4-KBS is essential to maintain the
methylation of the paternal ICR1 and thus affects the
transcription of the imprinted genes IGF2 and H19. As
expected, the observed function of Kaiso did not affect
the KvDMR1/ICR2 methylation, which is known to have
a ZFP57-dependent methylation maintenance [16], fur-
ther supporting the idea that the observed Kaiso effects
are specific and represent the long-sought alternative
methylation maintenance factor for ICR1 [17]. How can
this function be mediated? Like in the ICR1, it has been
shown for the RB1 locus that CTCF binding protects
against DNA methylation [24]. When this region gets
methylated (e.g. in cancer cells), Kaiso binds to its meth-
ylated recognition sites and induces epigenetic silencing
of the promoter, likely via associated repressor compo-
nents that include N-CoR and HDACs [20, 24, 25].
Crystal analyses showed that the overall structures of
Kaiso in complex with the KBS or methylated DNA are
nearly identical and manifest similar modes of DNA rec-
ognition [26]. Kaiso binding to methylated DNA motifs
is similar to that of its close relative ZBTB4 that binds
mostly on one strand, and when the CmGCmG motif is
bound, this could occur by two molecules of Kaiso, each
on one DNA strand [18]. When DNA is replicated, it is
hemi-methylated. Binding of Kaiso to the (still) methyl-
ated DNA strand could thus ensure maintenance of the
methylation mark. This leaves the possibility that al-
though the KBS in ICR1-B4 is essential, binding of Kaiso
to the methylated sites in the ICR1 is also necessary for
a proper ICR1 methylation maintenance. A loss of the
KBS in ICR1-B4 is observed in BWS patients with ICR1
microdeletions that individually vary in size, ranging
from 1.4 to 2.2 kbp and fusing the B-elements of the first
cluster (B1-3) to the B-elements of the second cluster of
ICR1 repeats (B5–B6) [6, 27, 28]. These deletions are on
the maternal, normally unmethylated ICR1 allele and
mostly affect CTS spacing. A CTS spacing similar to the
intact ICR1 results in moderate ICR1 inactivation and is
associated with stochastic gain of DNA methylation of
the maternal ICR1, whereas microdeletions with altered
CTS spacing result in severe ICR1 inactivation, associ-
ated with ICR1 hypermethylation [28]. CTS spacing thus
seems to be essential for maintaining the unmethylated
state of the maternal ICR1. If this spacing is dis-
turbed, a de novo methylation can occur. Using
CRISPR/Cas9, we generated a set of small deletions
which ablated Kaiso binding to one or both alleles.
Yet the DNA methylation status of the ICR1 is not
increased, unlike what is observed in patients with
the described ICR1-microdeletions, but rather a decrease
was observed. This suggests that the deletions generated
by CRISPR/Cas9 do not sufficiently perturb the spacing of
factors bound to the ICR1 on the maternal allele. The
decrease of methylation must occur on the paternal allele,
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and there is a causal connection of the epigenetic alter-
ation with the hampering of Kaiso binding to the KBS.
Nonetheless, we cannot exclude the possibility that Kaiso
binding still has to occur in a certain pattern on the pater-
nal ICR1 allele and not only to the KBS in B4 to maintain
the methylation. The depletion of Kaiso or the deletion of
the KBS in B4 is unlikely to affect CTCF binding to the
ICR1, since we already could show that maternally trans-
mitted ICR1 microdeletions mostly affect IC1 function
and CTCF binding by changing CTCF binding site
spacing. So does a 2.2-kb deletion that fuses B1 to B5 have
an efficiency of CTCF binding similar to a wild-type ICR1,
whereas a 1.8-kb deletion that fuses B2 to B5 has a lower
CTCF binding efficiency, although in both cases, the
complete B4 element with the KBS is deleted [28].
The observed demethylation of the ICR1 after Kaiso
depletion by lentiviral knockdown as well as the CRISPR/
Cas9 editing of the KBS in B4 goes along with a decrease
of IGF2 as well as of H19 expression. How can Kaiso
potentially mediate these transcriptional effects? From our
current understanding of an unmethylated ICR1 being a
prerequisite for H19 transcription and IGF2 inactivation, a
hypomethylation of an intact ICR1 should result—as
observed—in an IGF2 decrease; however, it should not
decrease also the transcription of H19. One explanation is
that Kaiso binds indeed to the KBS in B4 on both parental
alleles, since the binding motif cannot be methylated, but
on the maternal allele, this binding exerts functions that
strengthen the H19 promoter and thus increase H19 tran-
scription. Support for this functional model comes from
functional observations of a consensus KBS in close prox-
imity to the CTS in the human 5′ beta-globin insulator.
The presence of this KBS reduced the enhancer blocking
activity of CTCF in an insulation assay, suggesting that
the Kaiso-CTCF interaction negatively regulates CTCF
insulator activity [29]. By comparison of the expression
levels of genes whose proximal region including the
promoter is bound by Kaiso in several cell lines versus the
expression of the genes whose promoters are bound by
Kaiso in a cell type-specific manner, a positive correlation
between Kaiso binding and gene expression can be ob-
served, suggesting that Kaiso may recruit positively acting
transcription factors [30]. Although it is unlikely that
Kaiso binding to the KBS affects CTCF binding efficiency
[28], a composite CTCF- and Kaiso-KBS binding to the
unmethylated ICR1 might exert a role in insulation,
enhancer blocking and loop formation. Thus, Kaiso bind-
ing to the unmethylated ICR1 that is loaded with CTCF
could suggestively also represent a regulatory mechanism
for specific ICR1 function.
Since the KBS motif can be found also in other ICRs
than the ICR1 (compare Additional file 2: Table S1), it
can be speculated that Kaiso might have a methylation
maintenance effect also on these. However, our preliminary
data suggests that on at least four selected ICRs with a
KBS, no methylation change can be observed after shRNA-
mediated Kaiso depletion (compare Additional file 2:
Table S1). In addition to the methylation, Kaiso bind-
ing in the ICR1 affects also the transcription of IGF2
and H19 and we discussed already that this might not
directly be connected to the role of Kaiso in the methyla-
tion maintenance. From ten analysed imprinted genes,
only three showed a transcriptional dysregulation after
Kaiso knockdown, one being the already discussed IGF2
and the others the KCNQ1OT1 transcript and the PEG3
gene (compare Additional file 2: Table S1). In the light of
the proposed network of imprinted genes, it remains to be
seen if the observed transcriptional effects might be medi-
ated by the transcriptional finetuning of H19, that is
known to act as a transfactor for transcriptional regulation
of other imprinted genes [31].
What are the physiological consequences of Kaiso bind-
ing to the ICR1? It is known that Kaiso regulates several
genes including MMP7 [32, 33] and β-catenin [34]. How-
ever, deletion of the Kaiso gene causes no overt phenotype
in mice. Yet Kaiso-deficient ApcMin/+ mice, a model for
human familial adenomatous polyposis [35], exhibit de-
layed intestinal tumourigenesis [36]. In this context, it is
also noteworthy that Kaiso DNA binding and transcrip-
tional activity is attenuated by the interaction with the
p120 catenin protein [37], which is commonly reduced or
lost in colorectal tumours [38]. H19 has been observed to
be transcriptionally upregulated in a number of tumours,
and this upregulation is correlated with the increased
metastatic potential of several tumours [39]. If Kaiso is
responsible for H19 transcriptional fine tuning, H19
could be downregulated in the case of Kaiso binding
loss to the ICR1 and thus explain the protective find-
ings in Kaiso-deficient ApcMin/+ mice [36]. Further-
more, Nakagawa and coworkers demonstrated that
methylation-dependent loss of IGF2 imprinting was
present in colon tumours and normal colonic mucosa,
suggesting that IGF2 overexpression predisposes to
cancer [40]. If Kaiso binding to the ICR1 is necessary
for ICR1 methylation maintenance and IGF2 expression
from the methylated alleles, Kaiso-deficient ApcMin/+ mice
should display reduced ICR1 methylation and conse-
quently also reduced Igf2 expression (as suggested by our
knockdown experiments, see Fig. 3), also explaining the
delayed intestinal tumourigenesis. Thus, the concerted
reduction of H19 and IGF2 due to reduced Kaiso binding
to the ICR1 makes Kaiso an interesting potential target for
therapeutic interventions in cases of disease association
with H19/IGF2 overexpression.
Conclusions
Our studies demonstrate that Kaiso (ZBTB33) binds to
its unmethylated recognition site within the human
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ICR1 and that this binding is essential for the methyla-
tion maintenance of the paternal ICR1 allele and affects
the transcriptional regulation of the H19 gene. The
methylation of ICR2 on the same chromosome was
unaffected by the Kaiso depletion or ICR1-KBS deletion,
supporting the idea that Kaiso is an essential factor
particular for ICR1 function and represents the long-
sought alternative DMR methylation maintenance factor
for ICR1. Further studies are required to identify the
mechanisms responsible for these Kaiso-mediated effects.
Yet our findings open up new mechanistic insights into
the basic ICR1 functional regulation with implications on




Human primary fibroblasts with confirmed differential
methylation of the ICR1 were obtained with informed
written consent and ethics approval by the Independent
Ethics Committee (EK 159/08, Aachen). The study was
conducted according to the ethical principles of the
Declaration of Helsinki. Phoenix cells (HEK293T) (ob-
tained from JP) and primary fibroblast cells were grown in
DMEM (Gibco) and RPMI (Gibco), respectively, supple-
mented with 10 % FCS, 1 mM sodium pyruvate, 100 U/ml
penicillin and 100 μg/ml streptomycin.
Electrophoretic mobility shift assay (EMSA)
Single-stranded 5′-fluorescence-labelled (IRDyeTM-700)
forward and reverse oligonucleotides containing the
regular entire ICR1-KBS (5′-AGGGTCTCTGGCAGGC
ACAGAGCC-3′), B4-KBS (5′-GGCCTTTGGCAGGAA
CAGG-3′) or the known MMP7-KBS (5′-GTGCTT
CCTGCCAATAACG-3′) were annealed. The full-length
Kaiso-ORF was cloned into a pT7-CFE1-NFtag vector
(Pierce) and in vitro translated by the use of modified
HeLa cell extracts to generate functional full-length
N-terminally Flag-tagged protein according to the manu-
facturer’s protocol (Pierce). In supershift reactions, Flag-
tagged Kaiso was incubated with anti-Kaiso (Abcam),
anti-Flag antibody (Sigma-Aldrich) or unspecific IgG
antibodies (Diagenode) blocked by BSA. Protein extracts
of in vitro translated pT7-CFE1-NFtag vector backbone
were used as additional negative controls. In competi-
tion experiments, the protein was incubated with un-
labelled competitor oligos. All reactions were analysed
on a 4 % TBE polyacrylamide gel containing 2.5 %
glycerol and scanned with the Odyssey imager (LI-
COR Biosciences).
ChIP assay
ChIP was performed using a modified protocol of
Nelson, Denisenko and Bomsztyk (37) and the
SimpleChIP kit protocol (NEB). Primary fibroblasts (1 ×
107) of a proband with normal differentially methylated
ICR1 were cross-linked with a total of 1 % fresh formal-
dehyde (Thermo) and harvested as described [41]. Chro-
matin was fragmented in 90 cycles with a HTU-
Soni130-CV188 sonicator. Chromatin samples were in-
cubated with anti-Kaiso antibody (Bethyl) or unspecific
IgG antibodies (Diagenode) and bound to magnetic
beads for 2× washing with IP buffer, low and high salt
washes (NEB). Elution of chromatin from beads and re-
versal of cross-links were done according to the Simple-
ChIP kit protocol (NEB). Analysis of pulldown efficiency
was performed by qPCR using primers amplifying




C-3′) and MMP7 as previously published [41].
Lentiviral shRNA transfections
Downregulation of Kaiso in human primary fibro-
blasts was achieved by infecting primary human fibro-
blasts with human Kaiso-specific shRNAs in lentiviral
particles (SC38019-V) according to the manufacturer’s
recommendations (Santa Cruz Biotechnology, Inc.).
Scrambled shRNA with no endogenous mRNA target
(SC108080) was used as control (Santa Cruz Biotech-
nology, Inc.). At 24 h post infection, cells were
incubated in RPMI with 10 % FCS (Gibco) and
selected for puromycin resistance due to the integra-
tion and active transcription of the shRNA expression
construct.
CRISPR/Cas9-based genome editing
Two different synthetic guide RNAs (sgRNA) targeting
the human KBS-B4 sequence were synthesized as corre-
sponding double-stranded DNA oligos and after anneal-
ing cloned into the HpaI-XhoI sites downstream of the
human U6 promoter in the engineered lentiviral plasmid
pLeGO [23] as previously published [41]. A sgRNA
targeting the murine Rosa26 locus was used as a nega-
tive control. Retroviral packaging was performed using
ecotropic Phoenix cells (HEK293T). Lentivirus produc-
tion in 293T/17 (ATCC) cells was performed by calcium
phosphate transfection as previously described [42].
Lentiviral supernatant was collected 48, 56, 64 and 72 h
post-transfection, pooled and precipitated with PEG6000
and 0.3 M NaCl. Aliquots (100 μl) mixed with an equal
volume of media were incubated with human primary
fibroblast target cells for approximately 7 days, and
GFP+ cells were sorted by flow cytometry. On aver-
age, 1–5 % of cells were positive for the uptake/inte-
gration of the genome editing constructs.
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RNA purification, cDNA synthesis and quantitative PCR
RNA extraction was performed using the peqGOLD
total RNA kit (PeqLab) according to the manu-
facturer’s protocol. cDNA synthesis with oligo-dT
priming was performed using the M-MLV reverse
transcriptase from Invitrogen. For qPCR, the KAPA
SYBR FAST Master Mix (PeqLab) and LightCycler
480 detection system (Roche) were used. PDH and
B2M expressions were measured as controls for sam-
ple normalization.
Bisulfite pyrosequencing
Genomic DNA of primary fibroblasts was extracted with
the High Pure PCR Template preparation Kit (Roche)
according to the manufacturer’s instructions. Bisulfite
conversion of 500 ng genomic DNA per sample was
performed with the EpiTect Bisulfite Kit (Qiagen) ac-
cording to the manufacturer’s specifications. Quantifi-
cation of DNA methylation was carried out by PCR of
bisulfite-converted DNA and pyrosequencing using a
PyroMark Q96 ID instrument (Qiagen) and PyroMark
Gold Q96 reagents (Qiagen). Data were analysed using
the PyroMark CpG Software 1.0.11 (Qiagen).
Statistics
An independent two-sided t test was carried out for the
statistical analysis in the qPCR experiments following
shRNA-based knockdown or sgRNA-based genomic
editing in compared cell populations. Significance of the
paired ChIP experiments was calculated with a paired
two-sided t test. Values from all experiments were used
for calculation of the means and the respective SEMs.
Additional files
Additional file 1: Figure S1. Reduced binding of Kaiso to the ICR1
does not alter the methylation of the KvDMR1/ICR2. ICR1 methylation
was determined by pyrosequencing of two established differentially
methylated KvDMR1/ICR2 CpGs in bisulfite-treated DNA. Displayed
histogram values are represented as mean ± SEM from two replicate
analyses for each CG position. (A) Knockdown of Kaiso is not associated
with reduced methylation of endogenous KvDMR1/ICR2. (B) Cas9-
modified fibroblasts impaired for ICR1 methylation due to ICR1-BS
editing are not impaired for KvDMR1/ICR2 methylation. (JPG 129 kb)
Additional file 2: Table S1. Influence of Kaiso on other ICRs. Other ICRs
than the ICR1 based on (Court et al. [43]) on different chromosomes
were analysed for the presence of KBS and their number listed. In
addition, the presence of ZPF57 target sites (ZFP57TS) was analysed
(Y = yes, N = no) as well as the Kaiso knockdown effect on the
methylation of the DMR and the transcription of flanking imprinted
genes of the respective ICRs (n.d. = not determined, NO = no change
observed, UP = upregulated, DOWN = downregulated). (XLSX 13 kb)
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